News & Trends - Pharmaceuticals
New laws proposed for mergers and acquisitions
The federal government is proposing new laws that will require major merger and acquisition proposals to seek approval from the competition regulator.
The proposed reforms were announced by the Treasurer, Dr Jim Chalmers, in response to submissions made by the Australian Competition and Consumer Commission (ACCC), which advocated for a fit for purpose merger regime designed to effectively identify and prevent anti-competitive transactions.
“Higher prices, less choice and less innovation can result from weakened competition. Stronger merger laws are critical to ensure anti-competitive mergers do not proceed,” said ACCC Chair Gina Cass-Gottlieb.
Currently Australia’s merger regime does not require merger parties to notify the ACCC of proposed acquisitions or to wait for ACCC clearance before proceeding.
Despite over 1,400 mergers recorded last year, valued at approximately $300 billion, only around 330 were formally notified to the ACCC under the existing voluntary merger framework. The competition regulator is currently reviewing Sigma’s proposed $8.8 billion merger deal with pharmacy retailer Chemist Warehouse.
Scheduled to take effect on 1 January 2026, pending legislative approval by the parliament, the new laws propose the introduction of “cost recovery fees” for merger reviews, wherein higher-risk mergers would incur elevated fees. Treasury projections estimate fees ranging from $50,000 to $100,000 for most mergers, with exemptions granted to small businesses.
Treasurer Chalmers highlighted the potential economic detriment posed by certain mergers, particularly those driven “solely focused on squeezing out competitors to capture a larger percentage of the market”.
Moreover, the proposed reforms include provisions to address serial acquisitions, where multiple smaller transactions over time cumulatively undermine competition. ACCC Chair Cass-Gottlieb hailed these amendments as crucial in improving public trust in Australia’s competition laws.
Additionally, Treasurer Chalmers announced the appointment of respected industrial organisation economist Dr Philip Williams AM as a Commissioner of the ACCC and the confirmation of lawyer Stephen Ridgeway as an Associate Commissioner.
The government will consult on the final details of the laws before they are put before parliament later this year.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Will the new PBS campaign pressure the government to act?
Pharma News: The medicines industry is ramping up its campaign to slash delays in patient access to new and innovative […]
MoreNews & Trends - MedTech & Diagnostics
Private hospitals struggle despite surge in admissions: Financial crisis worsens as inflation outpaces benefits
MedTech & Diagnostics News: Private hospital admissions are on the rise, but this uptick is not enough to counter the […]
MoreDigital & Innovation
Health sector and government under scrutiny: Record data breaches expose millions
Digital & Innovation: The national privacy regulator has raised alarm over escalating threats, reporting a record surge in data breach notifications. […]
MoreMedical and Science
Diabetes research funding plummets by 35%: Consultation launched to reverse decline
Medical & Science: Australia’s diabetes crisis is deepening, with calls for urgent action growing louder. The Standing Committee on Health, […]
More